| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.6 |